GAS5 and breast cancer: A significant downregulation of GAS5 (GAS5-001) level was observed in 33 out of 43 (76.7%) BC tissues, with the overall mean level of GAS5 (GAS5-001) 3-fold lower than that of the adjacent normal bladder tissues.